New vaping laws aimed at regulating the supply and manufacture of vapes.

The TGA's new approach is designed to provide overarching guidance to help shape compliance across the sector.

A hypothetical scenario involving the marketing of pharmaceutical products.

The proposed welfare drug testing trial is yet another cruel, expensive and extremist extension of drug prohibition.

The article explains the current e-cigarette regulatory regime and proposed new Qld laws, and discusses the WHO report.

The popularity & continued development of prodrug formulations raises questions for the enforceability of existing metabolite claims.

Any IP licensing agreement that could affect competition, should be reviewed now to ensure competition compliance.

NSW citizens want a regime that tests for levels of illicit drugs in a person's system that would hinder driving ability.

Supplying a commercial quantity of prohibited drugs is an offence under the Drug Misuse and Trafficking Act 1985 (NSW).

The "Seretide" war reached the Full Court of the Federal Court in Australia this month. The central issue in the case involved the question of whether two flyers sent to some 14,000 general practitioners in Australia and two advertisements published in "Australian Doctor" magazine relating to Glaxo's "Seretide" combination inhaler were misleading and deceptive or likely to mislead or deceive in contravention of the Australian Trade Practices Act.

Pharmaceutical companies should be increasingly wary of implementing aggressive educational campaigns and should familiarise themselves with their compliance obligations.

The impact of the Ruling on the Simmonds' case will inevitably play out into the future.

What is pill testing? Europe & ACT lead the way & Qld follows with pill testing sites coming soon.

A 64 year old employee with six years' service has been awarded reinstatement by the Fair Work Commission (FWC).

On March 15, 2018, the Therapeutic Goods Administration (TGA) of Australia released revised (version 2.0) of the Australian Clinical Trial Handbook.

The US Court ruled that reverse patent settlements, or "pay for delay" agreements, may be illegal under anti-trust laws.

The term of a pharmaceutical patent may be extended if a product covered by the claims receives regulatory approval.

The article discusses the history of medicinal cannabis, the Australian market and the types of IP that can be utilised.

This approach to infringement by supply provisions in the Patents Act is a surprise for generic pharmaceutical companies.

One of the most common drug offences we see as criminal lawyers is possessing dangerous drugs under section 9 of the Drugs Misuse Act 1986 (Qld).